慢性心力衰竭的管理与减少的射出分数
Brandon Williamson1, Carl Tong2
1From the Texas A&M University Health Science Center, Bryan, TX (BW); Texas A&M University Health Science Center, Bryan, TX (CT). Bwilliamson@tamu.edu.
Journal of the American Board of Family Medicine : JABFM
|August 14, 2024
概括
本综述涵盖了心力衰竭与减少喷射率 (HFrEF) 的指导方针导向医学治疗. 它详细介绍了已建立的治疗方法和新选择,如sacubitril-valsartan和SGLT2抑制剂,用于慢性HFrEF管理.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 家庭医学 家庭医学 家庭医学
背景情况:
- 减少排气分数 (HFrEF) 的心力衰竭是家庭实践中常见的疾病.
- 有效的药理管理对于改善患者的治疗结果和生活质量至关重要.
研究的目的:
- 提供关于慢性HFrEF药理管理的全面概述.
- 要突出最新的美国心脏协会指南指南导向医学治疗 (GDMT).
主要方法:
- 审查当前的文献和临床指导方针.
- 对HFrEF的既定和新兴药理学药物的详细讨论.
- 专注于分类,GDMT和并发症管理.
主要成果:
- 已建立的治疗方法,包括β-阻断剂,ACE抑制剂,ARB和MRA仍然是基础的.
- 诸如萨库比特里尔-瓦尔萨坦和SGLT2抑制剂等较新的药物代表了HFrEF治疗的重大进展.
- 综合管理还包括解决并发病症,并考虑先进疗法.
结论:
- 坚持GDMT,结合新型疗法,对于最佳的HFrEF护理至关重要.
- 家庭医生在使用基于证据的药理策略来管理慢性HFrEF方面发挥着关键作用.
- 治疗建议的持续更新需要HFrEF管理的持续专业发展.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: β-Blockers
324
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


